Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants - Ueno, Mikako; Iwata-Yoshikawa, Naoko; Matsunaga, Akihiro; Okamura, Tadashi; Saito, Sho; Ashida, Shinobu; Yoshida, Isao; Nagashima, Mami; Asakura, Hiroyuki; Yaoita, Yuu; Suzuki, Jun; Sadamasu, Kenji; et al. (Antiviral research, 2022)
Keywords: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antibodies, Viral; Antineoplastic Agents, Immunological; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; COVID-19 Drug Treatment; Drug Combinations; Escape mutants; Humans; Leukocytes, Mononuclear; mAb; Neutralizing activity; Omicron variants; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Spike protein; SARS-CoV-2; Escape mutants; Spike protein; Neutralizing activity; Omicron variants; mAb